A Two-Part, Multicenter, Randomized, Clinical Trial to Study the Effects of Multiple Doses of MK-1029 on the Late Asthmatic Response to Lung Allergen Challenge in Asthmatics.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2016
At a glance
- Drugs MK 1029; Mometasone
- Indications Allergic asthma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 09 Feb 2012 Actual patients number is 16 as reported by ClinicalTrials.gov.
- 30 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 30 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.